Skip to main content

Centessa Pharmaceuticals plc

CNTADelisted Jun 24, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001847903

Centessa Pharmaceuticals plc was delisted on Jun 24, 2026; its insiders filed their last Form 4 on Jun 24, 2026; 161 institutions reported holding it in 13F filings for Q1 2026, worth $5.90B in total; Maverick Capital was the only superinvestor holding it.

13F holders, Q3 2022

Institutional positions in Centessa Pharmaceuticals plc as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
44
+3 vs. Q2 2022
Shares held
71.8M
−22.6K (0.0%) vs. Q2 2022
Total value
$288.7M
−$61.6M (−17.6%) vs. Q2 2022
New holders
6
6 more added
Sold out
3
17 more reduced

Compare with Q2 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting CNTA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2022: 44 institutions
Q1 2021: 0 institutionsQ2 2021: 50 institutionsQ3 2021: 40 institutionsQ4 2021: 47 institutionsQ1 2022: 44 institutionsQ2 2022: 41 institutionsQ3 2022: 44 institutionsQ4 2022: 44 institutionsQ1 2023: 44 institutionsQ2 2023: 45 institutionsQ3 2023: 49 institutionsQ4 2023: 58 institutionsQ1 2024: 69 institutionsQ2 2024: 80 institutionsQ3 2024: 103 institutionsQ4 2024: 114 institutionsQ1 2025: 130 institutionsQ2 2025: 117 institutionsQ3 2025: 125 institutionsQ4 2025: 147 institutionsQ1 2026: 161 institutionsQ2 2026: 0 institutions
Value heldQ3 2022: $288.7M
Q1 2021: $0Q2 2021: $1.05BQ3 2021: $947.5MQ4 2021: $807.8MQ1 2022: $669.1MQ2 2022: $350.3MQ3 2022: $288.7MQ4 2022: $194.4MQ1 2023: $257.5MQ2 2023: $435.4MQ3 2023: $469.6MQ4 2023: $567.4MQ1 2024: $840.7MQ2 2024: $781.2MQ3 2024: $1.74BQ4 2024: $2.08BQ1 2025: $1.80BQ2 2025: $1.62BQ3 2025: $3.11BQ4 2025: $3.60BQ1 2026: $5.90BQ2 2026: $0
Institutions holding CNTA and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 2026161$5.90B
Q4 2025147$3.60B
Q3 2025125$3.11B
Q2 2025117$1.62B
Q1 2025130$1.80B
Q4 2024114$2.08B
Q3 2024103$1.74B
Q2 202480$781.2M
Q1 202469$840.7M
Q4 202358$567.4M
Q3 202349$469.6M
Q2 202345$435.4M
Q1 202344$257.5M
Q4 202244$194.4M
Q3 202244$288.7M
Q2 202241$350.3M
Q1 202244$669.1M
Q4 202147$807.8M
Q3 202140$947.5M
Q2 202150$1.05B
Q1 20210$0

Institutions, Q3 2022

Shares, value and share of portfolio for each institution holding Centessa Pharmaceuticals plc; share changes are against Q2 2022.

Institutions holding CNTA in Q3 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Medicxi Ventures Management (Jersey) Ltd19,963,157$80.3M33.41%00.0%Unchanged
Index Venture Life Associates VI Ltd9,961,789$40.0M100.00%00.0%Unchanged
General Atlantic LLC9,681,818$38.9M0.46%00.0%Unchanged
BVF Inc6,894,345$27.7M1.14%00.0%Unchanged
Vida Ventures Advisors, LLC3,931,818$15.8M14.18%00.0%Unchanged
EcoR1 Capital, LLC3,236,352$13.0M0.38%+2,944,032+1,007.1%Added
OUP Management Co., LLC2,937,615$11.8M18.39%00.0%Unchanged
Janus Henderson Group PLC2,944,956$11.8M0.01%−483,564−14.1%Reduced
Price T Rowe Associates Inc2,445,983$9.83M0.00%−15,147−0.6%Reduced
Cormorant Asset Management, LP1,972,728$7.93M0.56%−954,545−32.6%Reduced
Samsara BioCapital, LLC1,693,736$6.81M1.59%00.0%Unchanged
Boxer Capital, LLC1,251,137$5.03M0.28%00.0%Unchanged
Franklin Resources Inc832,932$3.35M0.00%00.0%Unchanged
Kynam Capital Management, LP731,521$2.94M0.62%−26,327−3.5%Reduced
FMR LLC708,791$2.85M0.00%+698,491+6,781.5%Added
American Century Companies Inc515,746$2.07M0.00%−1,831−0.4%Reduced
Logos Global Management LP399,801$1.61M0.20%00.0%Unchanged
BlackRock Inc.293,511$1.18M0.00%−8,404−2.8%Reduced
Ensign Peak Advisors, Inc248,228$998.0K0.00%+125,157+101.7%Added
Affinity Asset Advisors, LLC242,517$975.0K0.45%+242,517New
Citadel Advisors LLC225,368$906.0K0.00%−65,215−22.4%Reduced
Woodline Partners LP178,568$718.0K0.01%−1,136,084−86.4%Reduced
Point72 Asset Management, L.P.117,800$474.0K0.00%−15,800−11.8%Reduced
Oasis Management Co Ltd.110,000$442.0K0.08%+52,300+90.6%Added
TD Asset Management Inc82,055$349.0K0.00%00.0%Unchanged
Manufacturers Life Insurance Company, The57,421$244.0K0.00%00.0%Unchanged
Alps Advisors Inc51,503$207.0K0.00%−4,282−7.7%Reduced
Jane Street Group, LLC29,911$120.0K0.00%−9,424−24.0%Reduced
Morgan Stanley16,494$67.0K0.00%−23,770−59.0%Reduced
Goldman Sachs Group Inc16,529$66.0K0.00%−14−0.1%Reduced
Geode Capital Management, LLC13,428$53.0K0.00%+13,428New
Compagnie Lombard Odier SCmA5,820$23.0K0.00%+5,820New
Tower Research Capital LLC (TRC)5,277$21.0K0.00%+3,800+257.3%Added
JPMorgan Chase & Co3,391$14.0K0.00%−175,023−98.1%Reduced
Advisor Group Holdings, Inc.1,885$7.00K0.00%−65−3.3%Reduced
UBS Group AG1,558$6.00K0.00%+1,558New
Adirondack Trust Co925$4.00K0.00%00.0%Unchanged
Cubist Systematic Strategies, LLC1,000$4.00K0.00%+432+76.1%Added
Citigroup Inc668$3.00K0.00%−557−45.5%Reduced
China Universal Asset Management Co., Ltd.481$2.00K0.00%+481New
Global Retirement Partners, LLC350$1.00K0.00%00.0%Unchanged
Crewe Advisors LLC220$1.00K0.00%00.0%Unchanged
Bank of America Corp166$00.00%−5,880−97.3%Reduced
Simplex Trading, LLC60$00.00%+60New
Baker Bros. Advisors LP0$00.00%−1,127,273−100.0%Sold out
Mirae Asset Global Investments Co., Ltd.0$00.00%−57,342−100.0%Sold out
State of Wyoming0$00.00%−96−100.0%Sold out